| Application no. and date | 01952304.2 (espacenet) (Federated) (European Patent Register), 20010628 | | Patent/reg. no. and date | DK/EP 1294715, 20070214 | | Publication date | 20030326 | | Priority no. and date | US 215508 P, 20000630, US 271845 P, 20010227 | | EP pub. no. and date |
EP 1294715 20030326 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P80701421DK00E | | Inventor | MCCLURE, Michael S.,
GlaxoSmithKline, Five MooreDrive,
PO Box 13398
Research Triangle Park,
NC 27709, US,
OSTERHOUT, Martin H.,
GlaxoSmithKline, Five Moore Drive,
PO Box 13398
Research Triangle Park,
NC 27709, US,
ROSCHANGAR, Frank,
GlaxoSmithKline, Five Moore Drive,
PO Box 13398
Research Triangle Park,
NC 27709, US,
SACCHETTI, Mark J.,
GlaxoSmithKline, Five MooreDri verive,
PO Box 13398
Research Triangle Park,
NC 27709, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 31/519 (2006.01) , A61P 17/06 (2006.01) , A61P 35/00 (2006.01) , C07D 405/04 (2006.01) , C07D 417/04 (2006.01) , C07D 471/04 (2006.01) | | Title | Quinazolinditosylatsaltforbindelser | | Int. application no. | US2001020706 | | Int. publication no. | WO2002002552 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
